Literature DB >> 6458813

Suppressor factor from a T cell hybrid inhibits delayed-type hypersensitivity responses to azobenzenearsonate.

R B Whitaker, J T Nepom, M S Sy, M Takaoki, C F Gramm, I Fox, R N Germain, M J Nelles, M I Greene, B Benacerraf.   

Abstract

By using polyethylene glycol 1540, BW5147 AKR T lymphoma cells were fused with splenocytes from A/J mice treated so as to induce suppressor T cells specific for azobenzenearsonate (ABA). Of 576 microwells originally seeded, 132 demonstrated growing cell clones, 4 of which produced an ABA-binding supernatant factor. When tested in vivo for suppression of delayed-type hypersensitivity to ABA, two of these cell lines, A4 and F12, were shown to produce suppressive supernatant factors. Fluorescence analysis of the F12 cells with appropriate antisera demonstrated this T cell hybrid to be Thy 1.2+, Lyt 1+,2-, and surface immunoglobulin negative, the surface marker phenotype of conventional ABA-specific suppressor T cells. This cloned suppressor cell line, F12, produces a culture supernatant factor that is suppressive at dilutions up to 1:100 and has provided material for genetic and immunochemical analysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458813      PMCID: PMC349055          DOI: 10.1073/pnas.78.10.6441

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

2.  Regulation of antibody response in different immunoglobulin classes. V. Establishment of T hybrid cell line secreting IgE class-specific suppressor factor.

Authors:  T Watanabe; M Kimoto; S Maruyama; T Kishimoto; Y Yamamura
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  Production of an H--2-related suppressor factor by a hybrid T-cell line.

Authors:  M J Taussig; J R Corvalan; R M Binns; A Holliman
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

4.  T cell hybrids with specificity for individual antigens.

Authors:  N H Ruddle
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  Mechanisms of regulation of cell-mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells.

Authors:  B A Bach; L Sherman; B Benacerraf; M I Greene
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

Review 6.  Regulation of immune responses by suppressor T cells.

Authors:  C W Pierce; J A Kapp
Journal:  Tohoku J Exp Med       Date:  1976       Impact factor: 1.848

Review 7.  Specific blocking factors--are they important?

Authors:  K E Hellström; I Hellström; J T Nepom
Journal:  Biochim Biophys Acta       Date:  1977-12-23

8.  Heterogeneity of an intrastrain cross-reactive idiotype associated with anti-p-azophenylarsonate antibodies of A/J mice.

Authors:  E Lamoyi; P Estess; J D Capra; A Nisonoff
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

9.  Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.

Authors:  L L Perry; B Benacerraf; M I Greene
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

10.  Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line.

Authors:  M Taniguchi; J F Miller
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  11 in total

1.  CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells.

Authors:  D B Weiner; J Liu; N Hanna; J A Bluestone; J E Coligan; W V Williams; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 2.  I-J subregion and suppressor signals.

Authors:  J S Bromberg; A Tominaga; M Takaoki; M I Greene
Journal:  Surv Immunol Res       Date:  1982

3.  Immunotherapy of collagen-induced arthritis by a T-cell antiproliferative molecule.

Authors:  D J Spannaus-Martin; R Holmdahl; T F Kresina
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.

Authors:  F Sinigaglia; C Gotti; R Castagnoli; F Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Human T cell hybridomas secreting immune interferon.

Authors:  J Le; J Vilcek; C Saxinger; W Prensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.

Authors:  R L Mosley; J W Murphy; R A Cox
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).

Authors:  F R Khakpour; J W Murphy
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

8.  Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses.

Authors:  D H Sherr; M Minami; K Okuda; M E Dorf
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

9.  Igh variable region-restricted T cell interactions. Genetic restriction of an antigen-specific suppressor inducer factor is imparted by an I-J+ antigen-nonspecific molecule.

Authors:  P M Flood; A Lowy; A Tominaga; B Chue; M I Greene; R K Gershon
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells.

Authors:  M Takaoki; M S Sy; A Tominaga; A Lowy; M Tsurufuji; R Finberg; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.